SCHEMBL5171978

SCHEMBL5171978

CC(O)c1ccc([C@@H](C(N)=O)C(=O)Nc2ccc(N(C)C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
ALDH1A1 P00352 5/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 3/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
TP53 P04637 2/20 0.43
LMNA P02545 2/20 0.43
MCL1 Q07820 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 1/20 0.43
ROCK2 O75116 1/20 0.42
NOX1 Q9Y5S8 2/20 0.41
ESR2 Q92731 1/20 0.41
NR4A1 P22736 1/20 0.41
HPGD P15428 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5171421 0.84 MAPT (0.63) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL5171535 0.82 CNR1 (0.45) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL631407 0.79 SMN1; SMN2 (0.45) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL8738834 0.75 MAPT (0.58) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL5172899 0.75 ALDH1A1 (0.57) MAPTSMN1; SMN2ALDH1A1GAANPC1
SCHEMBL17160801 0.74 ALDH1A1 (0.55) MAPTALDH1A1KMT2AGAATP53
SCHEMBL4886100 0.74 ALDH1A1 (0.55) MAPTALDH1A1KMT2AGAATP53
SCHEMBL1379670 0.71 MAPT (0.66) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL29522596 0.71 ALDH1A1 (0.60) MAPTSMN1; SMN2ALDH1A1KMT2AGAA
SCHEMBL2107534 0.70 HDAC1 (0.76)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed